Q3 2019 Holdings
Filed 2019-11-14 | 55 holdings | $3.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $1.1M | 13,684 | 32.6% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $654.0K | 9,700 | 19.4% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $596.0K | 6,190 | 17.7% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $432.0K | 12,005 | 12.8% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $280.0K | 2,112 | 8.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $261.0K | 1,123 | 7.7% |
| Ishares TR(IBB) | NASDAQ BIOTECH | 464287556 | $12.4K | 125,000 | 0.4% |
| Ishares TR(IBB)Call | NASDAQ BIOTECH | 464287556 | $8.5K | 85,000 | 0.3% |
| Direxion SHS ETF TR(LABUUSD) | SP BIOTCH BL NEW | 25490K323 | $3.1K | 99,855 | 0.1% |
| Mettler Toledo International(MTD) | COM | 592688105 | $2.3K | 3,235 | 0.1% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $1.7K | 33,000 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $1.5K | 18,020 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $1.4K | 4,721 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $1.4K | 8,279 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $1.2K | 20,124 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $973 | 9,933 | 0.0% |
| Qiagen NV(QGEN) | SHS NEW | N72482123 | $951 | 28,858 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $941 | 9,699 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $865 | 613,551 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $798 | 138,461 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $791 | 10,659 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $771 | 8,534 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $677 | 2,439 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $632 | 18,631 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $560 | 14,215 | 0.0% |
| Celgene Corp(CELG) | COM | 151020104 | $559 | 5,625 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $542 | 13,214 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $520 | 50,378 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $510 | 33,641 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $498 | 6,780 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $487 | 17,339 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $475 | 20,844 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $460 | 9,479 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $453 | 10,852 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $447 | 9,770 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $423 | 3,674 | 0.0% |
| Zogenix Inc | COM NEW | 98978L204 | $389 | 9,725 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $384 | 30,075 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $380 | 28,490 | 0.0% |
| BIO Techne Corp(TECH) | COM | 09073M104 | $303 | 1,551 | 0.0% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $297 | 1,985 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $294 | 1,518 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $282 | 3,127 | 0.0% |
| Checkpoint Therapeutics Inc(CKPTUSD) | COM | 162828107 | $281 | 112,760 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $279 | 3,498 | 0.0% |
| Grifols S A(GRFS) | SP ADR REP B NVT | 398438408 | $264 | 13,196 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $261 | 3,926 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $259 | 4,082 | 0.0% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $242 | 2,428 | 0.0% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $235 | 12,927 | 0.0% |